company background image
A060590 logo

CTCBIO KOSDAQ:A060590 Stock Report

Last Price

₩6.45k

Market Cap

₩154.2b

7D

-3.3%

1Y

-36.8%

Updated

25 Dec, 2024

Data

Company Financials

CTCBIO Inc.

KOSDAQ:A060590 Stock Report

Market Cap: ₩154.2b

A060590 Stock Overview

Provides various pharmaceutical products in South Korea and internationally. More details

A060590 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

No risks detected for A060590 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

CTCBIO Inc. Competitors

Kyung Dong Pharmaceutical

KOSDAQ:A011040

₩169.5b

HANDOK

KOSE:A002390

₩167.6b

Jeil PharmaceuticalLtd

KOSE:A271980

₩171.1b

High Tech Pharm

KOSDAQ:A106190

₩147.2b

Price History & Performance

Summary of share price highs, lows and changes for CTCBIO
Historical stock prices
Current Share Price₩6,450.00
52 Week High₩10,900.00
52 Week Low₩6,000.00
Beta0.41
1 Month Change-7.19%
3 Month Change-11.64%
1 Year Change-36.83%
3 Year Change-29.04%
5 Year Change5.74%
Change since IPO26.51%

Recent News & Updates

Recent updates

CTCBIO's (KOSDAQ:060590) Shareholders Are Down 64% On Their Shares

Mar 15
CTCBIO's (KOSDAQ:060590) Shareholders Are Down 64% On Their Shares

Is CTCBIO (KOSDAQ:060590) Using Too Much Debt?

Jan 21
Is CTCBIO (KOSDAQ:060590) Using Too Much Debt?

Would Shareholders Who Purchased CTCBIO's (KOSDAQ:060590) Stock Five Years Be Happy With The Share price Today?

Nov 29
Would Shareholders Who Purchased CTCBIO's (KOSDAQ:060590) Stock Five Years Be Happy With The Share price Today?

Shareholder Returns

A060590KR PharmaceuticalsKR Market
7D-3.3%-0.5%-1.9%
1Y-36.8%0.8%-9.5%

Return vs Industry: A060590 underperformed the KR Pharmaceuticals industry which returned 2.4% over the past year.

Return vs Market: A060590 underperformed the KR Market which returned -9% over the past year.

Price Volatility

Is A060590's price volatile compared to industry and market?
A060590 volatility
A060590 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A060590 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A060590's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993249Mingoo Leewww.ctcbio.com

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19.

CTCBIO Inc. Fundamentals Summary

How do CTCBIO's earnings and revenue compare to its market cap?
A060590 fundamental statistics
Market cap₩154.21b
Earnings (TTM)-₩16.79b
Revenue (TTM)₩138.95b

1.1x

P/S Ratio

-9.2x

P/E Ratio

Is A060590 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A060590 income statement (TTM)
Revenue₩138.95b
Cost of Revenue₩92.35b
Gross Profit₩46.60b
Other Expenses₩63.39b
Earnings-₩16.79b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-702.41
Gross Margin33.54%
Net Profit Margin-12.09%
Debt/Equity Ratio36.5%

How did A060590 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 00:46
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CTCBIO Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
JongHoon LeeDaishin Securities Co. Ltd.
Al Eum LeeiM Securities
Jae Hoon ShinLS Securities Co., Ltd.